Home / $BIOAF / Chart / Market / Uptick Featured Interviews / CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF) CEO Dr. Mark Day of Bioasis Technologies Inc., gives details on developing xB3 for treatment of brain cancer and neurodegenerative disease.

CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF) CEO Dr. Mark Day of Bioasis Technologies Inc., gives details on developing xB3 for treatment of brain cancer and neurodegenerative disease.

in $BIOAF, Chart, Market, Uptick Featured Interviews

President Dr. Check Day of Bioasis Technologies Inc. (OTCQB: BIOAF), joins Stock Day to give points of interest on creating xB3 for treatment of mind growth and neurodegenerative malady.